We offer LC-MS bioanalytical services that support timely, informed study decisions. From flexible non-regulated research through regulated clinical bioanalysis, Veloxity delivers high-quality data you can rely on — precisely when you need it.
At Veloxity, our bioanalytical services are designed for speed, precision and flexibility. Whether you’re optimizing leads, supporting GLP studies or generating GCP-aligned clinical data, our approach emphasizes consistency and quality at every step.
Capabilities include:
We support the full drug development lifecycle, helping teams generate decision-driving data at every step.
Our flexible, responsive model supports sponsors across biotech, pharmaceutical and animal health drug development.
We support programs across complex and fast-moving therapeutic areas where data integrity and turnaround speed are critical.
Whether you’re working with traditional or challenging matrices, our team can develop and apply fit-for-purpose bioanalytical approaches to support your protocol.
In this report, Veloxity Labs details how we overcame critical selectivity challenges during a medical device study requiring ultra-sensitive bioanalysis in human plasma. By developing and validating a method with a 30 pg/mL LLOQ — while navigating unexpected interference — we optimized sample prep, chromatography and mobile phases to reduce analysis time by 70%. The result: a robust, cost-effective solution ready for clinical development. Download the full report to see how Veloxity’s expertise in bioanalytical method development supports success in pharma and biotech.
Talk with our scientists about your study, method development needs, sample analysis or timeline.
